Skip to content

RAPP · Rapport Therapeutics, Inc.

−6.8% on Oct 16

☆ Add to watchlist

Updated Oct 17 · 9 feeds behind: FDA drug approvals, 4 days, and 8 more · Every feed →

On this page

The market view

Price chart

The interactive RAPP chart (by TradingView) loads here.

Our take

5 rules fired on RAPP

In short: none of these rules has solid or some evidence yet, so they show no clear lean on RAPP.

How each did in past tests, against similar stocks over 3 months. Past results don't predict future ones.

All 5 rules
The 0–100 score for RAPP, and which of these rules are open on it right now
Members see one number for how strongly these rules agree on RAPP, and the day each rule fired. Better-tested rules count more, and so do different kinds of filings that point the same way.
See pricing →
Already a member? Sign in

Compare with this company’s history

Is disclosure activity unusual?

See how many different insiders or members of Congress reported purchases or sales of RAPP. Each bar covers 28 days, by disclosure date. Several trades by one person count once in each group and period.

Latest period: Sep 23, 2026–Oct 20, 2026 · UTC dates · today is excluded

Insider sales

Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual.

Latest 28 days
2
Earlier median
2
Earlier range
2–2
Distinct filers per 28 daysScale: 0–2
Oct 22, 2025Oct 20, 2026
Earlier periodsLatest 28 daysEarlier median 2Limited or missing history

Who appears in the latest period?

Up to three filers; one example disclosure each.

Inspect this period’s filings

The history behind this view

First stored company disclosure: Jul 1, 2026. Newest disclosure across this feed: Oct 16, 2026.

Earlier periods in the comparison: 3. Outlined periods are missing data, so they are left out of the comparison. The chart scale changes with the category.

Exact counts, dates and filings for all four categories
Insider purchases · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 0; range: 0–0.

Insider purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 20260Within stored history
Jul 29, 2026–Aug 25, 20260Within stored history
Aug 26, 2026–Sep 22, 20260Within stored history
Sep 23, 2026–Oct 20, 2026Latest period0Within stored history
Insider sales · Short history

Only 3 earlier periods are on file to compare with. We need at least 6 full periods before calling a count unusual. Earlier median: 2; range: 2–2.

Insider sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 20262Within stored history
Jul 29, 2026–Aug 25, 20262Within stored history
Aug 26, 2026–Sep 22, 20262Within stored history
Sep 23, 2026–Oct 20, 2026Latest period2Within stored history
Congress purchases · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress purchases: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 2026—Unavailable
Jul 29, 2026–Aug 25, 2026—Unavailable
Aug 26, 2026–Sep 22, 2026—Unavailable
Sep 23, 2026–Oct 20, 2026Latest period—Unavailable
Congress sales · History unavailable

No completed-period disclosures for this company are available in this source. Missing history is not zero activity. Earlier median: —; range: unavailable.

Congress sales: distinct filers in stored disclosures
Period and filingsFilersHistory
Oct 22, 2025–Nov 18, 2025—Unavailable
Nov 19, 2025–Dec 16, 2025—Unavailable
Dec 17, 2025–Jan 13, 2026—Unavailable
Jan 14, 2026–Feb 10, 2026—Unavailable
Feb 11, 2026–Mar 10, 2026—Unavailable
Mar 11, 2026–Apr 7, 2026—Unavailable
Apr 8, 2026–May 5, 2026—Unavailable
May 6, 2026–Jun 2, 2026—Unavailable
Jun 3, 2026–Jun 30, 2026—Unavailable
Jul 1, 2026–Jul 28, 2026—Unavailable
Jul 29, 2026–Aug 25, 2026—Unavailable
Aug 26, 2026–Sep 22, 2026—Unavailable
Sep 23, 2026–Oct 20, 2026Latest period—Unavailable
How to read this comparison

The median is the middle count in up to 12 earlier, non-overlapping 28-day periods; the range runs from the smallest to the largest count. The latest period is excluded from both. A comparison needs at least 6 earlier periods, including 3 with activity. The feed’s latest disclosure must be within 7 days of the current period’s end. This freshness check does not verify complete collection.

Insiders include individuals and reporting entities; only purchase and sale codes enter this view. Congress counts reporting members, including their disclosed family transactions. The same filer can appear in purchases and sales, so these categories should not be added into a net count.

These are stored disclosures, not a complete measure of trading. Reporting delays and collection gaps can change the comparison. More activity does not identify a motive or predict a stock’s return.

Company timeline

What has been happening?

May 1, 2026–Oct 16, 2026. Select a month in a category to inspect its records.

Company filings

Insiders

Insiders · Oct 2026

  1. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Oct 6, 2026

  2. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Oct 7, 2026

  3. Filed
  4. Disclosed
    Cheryl Gault · Sale

    Transaction dated Sep 30, 2026

  5. Disclosed
    Cheryl Gault · Sale

    Transaction dated Sep 30, 2026

All 33 records in this snapshot
  1. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Oct 6, 2026

  2. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Oct 7, 2026

  3. Filed
  4. Disclosed
    Cheryl Gault · Sale

    Transaction dated Sep 30, 2026

  5. Disclosed
    Cheryl Gault · Sale

    Transaction dated Sep 30, 2026

  6. Filed
  7. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Sep 23, 2026

  8. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Sep 23, 2026

  9. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Sep 23, 2026

  10. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Sep 8, 2026

  11. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Sep 8, 2026

  12. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Aug 25, 2026

  13. Disclosed
    Krishnaswamy Yeleswaram · Sale

    Transaction dated Aug 25, 2026

  14. Disclosed
    Krishnaswamy Yeleswaram · Sale

    Transaction dated Aug 24, 2026

  15. Disclosed
    Krishnaswamy Yeleswaram · Sale

    Transaction dated Aug 25, 2026

  16. Filed
  17. Filed
  18. Disclosed
    Krishnaswamy Yeleswaram · Sale

    Transaction dated Aug 19, 2026

  19. Filed
  20. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Aug 10, 2026

  21. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Aug 11, 2026

  22. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Aug 10, 2026

  23. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Aug 11, 2026

  24. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Aug 11, 2026

  25. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Jul 27, 2026

  26. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Jul 27, 2026

  27. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Jul 14, 2026

  28. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Jul 14, 2026

  29. Disclosed
    Abraham Ceesay · Sale

    Transaction dated Jun 29, 2026

  30. Disclosed
    Cheryl Gault · Sale

    Transaction dated Jun 30, 2026

  31. Filed
  32. Filed
  33. Filed

Month counts include every record on file. The lists show the newest records on this page. A dash means none on file that month. Trades use disclosure dates; contract dates follow the source record. Nearby events do not establish the cause of a price move.

Who's buying and selling · last 90 days

Congress

No Congress trades on RAPP disclosed in the last 90 days.

See every Congress trade on RAPP →

Company insiders

0 buys · 9 sells (21 filed lots) · $7M sold

  1. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$108Kdisclosed Oct 8 · filed 2 days after the trade
  2. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$35.2Kdisclosed Oct 8 · filed 1 day after the trade
  3. ▼ SELLCheryl Gault Chief Operating OfficerRAPP Rapport Therapeutics, Inc.$262Kdisclosed Oct 1 · filed 1 day after the trade
  4. ▼ SELLCheryl Gault Chief Operating OfficerRAPP Rapport Therapeutics, Inc.$70Kdisclosed Oct 1 · filed 1 day after the trade
  5. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$1.8Kdisclosed Sep 24 · filed 1 day after the trade
  6. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$8.6Kdisclosed Sep 24 · filed 1 day after the trade
  7. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$76.2Kdisclosed Sep 24 · filed 1 day after the trade
  8. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$325Kdisclosed Sep 9 · filed 1 day after the trade
  9. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$49.2Kdisclosed Sep 9 · filed 1 day after the trade
  10. ▼ SELLKrishnaswamy Yeleswaram Chief Development OfficerRAPP Rapport Therapeutics, Inc.$1Mdisclosed Aug 26 · filed 1 day after the trade
See every insider trade on RAPP →

Filings & events

Company filings (8-K) 31

Events the company must report to the SEC within days — results, deals, departures, restatements.

What it files 8-Ks about

  • Quarterly or yearly results · item 2.025
  • Other events · item 8.015
  • Shared information with investors · item 7.014
  • Shareholder vote results · item 5.072
  • Signed a major agreement · item 1.012
  • Sold shares privately · item 3.021

Filing red flags 15

Warning signs in the company's own SEC filings — going-concern doubts, control weaknesses, staff comment letters, late filings, restatements, Wells notices, clinical holds, dividend cuts.

FDA and clinical trials 1

Drug approvals, recalls, clinical-trial updates and FDA advisory meetings.

Planned insider sales (Form 144) 30

Notices insiders file before they sell certain shares, such as ones they got straight from the company.

5 in the last 90 days · 30 notices on file

The notices on file don't give the sale's size; each sale shows up under company insiders once it is reported.

5% owners (13D / 13G) 3

Investors who reported owning 5% or more — 13D for owners who may push for changes, 13G for owners who just hold.

Push for changes, or just hold?

  • 13D, may push for changes: 1 filing
  • 13G, just holds: 2 filings

Filed by BlackRock, Inc. · Sofinnova Venture Partners XI, L.P. · Third Rock Ventures V, L.P.

Biggest named funds (13F)

The largest RAPP holdings among the well-known funds whose quarterly 13F filings we read — opens here.

Every disclosed trade on RAPP

  1. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$108Kdisclosed Oct 8 · filed 2 days after the trade
  2. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$35.2Kdisclosed Oct 8 · filed 1 day after the trade
  3. ▼ SELLCheryl Gault Chief Operating OfficerRAPP Rapport Therapeutics, Inc.$262Kdisclosed Oct 1 · filed 1 day after the trade
  4. ▼ SELLCheryl Gault Chief Operating OfficerRAPP Rapport Therapeutics, Inc.$70Kdisclosed Oct 1 · filed 1 day after the trade
  5. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$1.8Kdisclosed Sep 24 · filed 1 day after the trade
  6. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$8.6Kdisclosed Sep 24 · filed 1 day after the trade
  7. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$76.2Kdisclosed Sep 24 · filed 1 day after the trade
  8. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$325Kdisclosed Sep 9 · filed 1 day after the trade
  9. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$49.2Kdisclosed Sep 9 · filed 1 day after the trade
  10. ▼ SELLKrishnaswamy Yeleswaram Chief Development OfficerRAPP Rapport Therapeutics, Inc.$1Mdisclosed Aug 26 · filed 1 day after the trade
  11. ▼ SELLKrishnaswamy Yeleswaram Chief Development OfficerRAPP Rapport Therapeutics, Inc.$658Kdisclosed Aug 26 · filed 2 days after the trade
  12. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$938Kdisclosed Aug 26 · filed 1 day after the trade
  13. ▼ SELLKrishnaswamy Yeleswaram Chief Development OfficerRAPP Rapport Therapeutics, Inc.$827Kdisclosed Aug 26 · filed 1 day after the trade
  14. ▼ SELLKrishnaswamy Yeleswaram Chief Development OfficerRAPP Rapport Therapeutics, Inc.$20.2Kdisclosed Aug 20 · filed 1 day after the trade
  15. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$391Kdisclosed Aug 12 · filed 2 days after the trade
  16. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$282Kdisclosed Aug 12 · filed 1 day after the trade
  17. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$651Kdisclosed Aug 12 · filed 2 days after the trade
  18. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$172Kdisclosed Aug 12 · filed 1 day after the trade
  19. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$937Kdisclosed Aug 12 · filed 1 day after the trade
  20. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$299disclosed Jul 29 · filed 2 days after the trade
  21. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$92.8Kdisclosed Jul 29 · filed 2 days after the trade
  22. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$218Kdisclosed Jul 15 · filed 1 day after the trade
  23. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$111Kdisclosed Jul 15 · filed 1 day after the trade
  24. ▼ SELLCheryl Gault Chief Operating OfficerRAPP Rapport Therapeutics, Inc.$43.2Kdisclosed Jul 1 · filed 1 day after the trade
  25. ▼ SELLAbraham Ceesay Chief Executive OfficerRAPP Rapport Therapeutics, Inc.$292Kdisclosed Jul 1 · filed 2 days after the trade
See all 29 trades on RAPP →
People & votes

Which members of Congress traded RAPP, sponsored bills that touch it and voted on them — opens here.